Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Supplement Substantiation Claims Guidance Aims For Clarity

This article was originally published in The Tan Sheet

Executive Summary

FDA expects a new guidance detailing the boundaries of "competent and reliable scientific information" will enhance consumer confidence in supplement claims

You may also be interested in...



Supplement Claim Guidance Stresses Human Studies, But Leaves Questions

An FDA guidance could leave dietary supplement firms confused on what is appropriate evidence for substantiating structure/function claims

Supplement Claim Guidance Stresses Human Studies, But Leaves Questions

An FDA guidance could leave dietary supplement firms confused on what is appropriate evidence for substantiating structure/function claims

Supplement Claim Guidance Stresses Human Studies, But Leaves Questions

An FDA guidance could leave dietary supplement firms confused on what is appropriate evidence for substantiating structure/function claims

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS097499

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel